Valerie Suski

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

Robert J. Fox, Christopher S. Coffey, Robin Conwit et al. · New England Journal of Medicine · 2018 · 270 citations · Full text

Differential tractography as a track-based biomarker for neuronal injury

Fang‐Cheng Yeh, Islam Zaydan, Valerie Suski et al. · NeuroImage · 2019 · 148 citations · Full text

Neuroimaging Biomarkers, Neuroanatomy, Neurological Function +8

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

Andrew McGarry, Michael McDermott, Karl Kieburtz et al. · Neurology · 2016 · 135 citations · Full text

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis

Robert J. Fox, Christopher S. Coffey, Merit Cudkowicz et al. · Contemporary Clinical Trials · 2016 · 66 citations · Full text

Neurological Disorder, Clinical Neurology, Clinical Trials +6

Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

Erin Furr Stimming, Daniel O. Claassen, Elise Kayson et al. · The Lancet Neurology · 2023 · 60 citations

Placebo-controlled Trial, Rehabilitation, Neurology +2